Blog

CRISPR Technology Seeking to Inactivate Mutated Genes in Lung Cancer – OncLive


OncLive

CRISPR Technology Seeking to Inactivate Mutated Genes in Lung Cancer
OncLive
Academic researchers are hoping that their efforts on the gene-editing technology of CRISPR (clustered regularly interspaced short palindromic repeats) will lead to the ability of turning off mutated genes in patients with a variety of malignancies

2017-08-15 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.